Conventional versus intensive T1DM tx not tied to menopause

January 9, 2014
Conventional versus intensive T1DM tx not tied to menopause

(HealthDay)—For women with type 1 diabetes, intensive versus conventional treatment is not associated with menopause risk, although greater insulin dose is associated with lower natural menopause risk, according to research published in Diabetes Care.

Catherine Kim, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues conducted a secondary analysis of 657 women with in the randomized Diabetes Control and Complications Trial (DCCT) and its observational follow-up, the Epidemiology of Diabetes Interventions and Complications (EDIC) study. The impact of intensive versus conventional treatment on was assessed.

After an average follow-up of 28 years, by EDIC year 18, the researchers found that 38 percent of women had experienced natural menopause and 18 percent had experienced surgical menopause. In intensive versus control groups, the ages at natural menopause (49.9 versus 49.0 years; P = 0.28) and surgical menopause (40.8 versus 42.0 years; P = 0.31) were similar. Treatment group, hemoglobin A1c (HbA1c), and microvascular complications were not linked to the risk of natural or surgical menopause in multivariate models. The risk of natural menopause was decreased with each 10 unit/day increase in insulin dosage (hazard ratio, 0.91), while each kg/m² increase in correlated with an elevated risk of surgical menopause (hazard ratio, 1.08).

"In the DCCT/EDIC, intensive versus conventional treatment group and HbA1c level were not associated with menopause risk," the authors write. "Greater insulin dose was associated with lower menopause risk."

Several pharmaceutical companies provided free or discounted supplies or equipment to support participants' adherence to the study.

Explore further: Does menopause matter when it comes to diabetes?

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study ties early menopause to heart attack, stroke

September 28, 2012

Women who experience early menopause are more likely to have a heart attack or stroke than women whose menopause occurs at a later age, according to a new study by Melissa Wellons, M.D., assistant professor of Medicine in ...

Cardiac function unaffected by prior intensive insulin therapy

April 12, 2013

(HealthDay)—There was no effect of intensive versus conventional insulin therapy during the Diabetes Control and Complications Trial (DCCT) on cardiac parameters as assessed by cardiac magnetic resonance (CMR) in the Epidemiology ...

Recommended for you

Do germs cause type 1 diabetes?

May 16, 2016

Germs could play a role in the development of type 1 diabetes by triggering the body's immune system to destroy the cells that produce insulin, new research suggests.

New gene for familial high cholesterol

May 12, 2016

New research from Denmark reveals the gene that explains one quarter of all familial hypercholesterolemia with very high blood cholesterol. Familial hypercholesterolemia is the most common genetic disorder leading to premature ...

Melatonin signaling is a risk factor for type 2 diabetes

May 12, 2016

A sleeping pancreas releases less insulin, but how much insulin drops each night may differ from person to person, suggests a study published May 12, 2016 in Cell Metabolism. Up to 30 percent of the population may be predisposed ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.